Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system

Cancer Prevention Research

Volumn 4, Issue 10, 2011, Pages 1655-1664

  Chaudhary, Abhishek ^a   Sutaria, Dhruvitkumar ^a   Huang, Ying ^a   Wang, Jeffrey ^a   Prabhu, Sunil ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZOXYMETHANE; CALCIUM; FOLINIC ACID; NANOPARTICLE;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; HISTOCHEMISTRY; MALE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPIRIN; AZOXYMETHANE; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FOLIC ACID; LACTIC ACID; MALE; NANOPARTICLES; POLYGLYCOLIC ACID; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN B COMPLEX;

EID: 80053916789     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0129     Document Type: Article

References (47)

1. American Cancer Society. Cancer facts and figures 2010. Atlanta, GA;2010.
2. Clapper ML, Chang WC, Meropol NJ. Chemoprevention of colorectal cancer. Curr Opin Oncol 2001;13:307-13. (Pubitemid 32578998)
3. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 2004;54:150-80. (Pubitemid 38812180)
4. Greenwald P. Cancer chemoprevention. BMJ 2002;324:714-8.
5. Sporn MB. Prevention of cancer in the next millennium. Cancer Res 1999;59:4743-58.
6. Gustafson-Svard C, Lilja I, Hallbook O, Sjodahl R. Cyclo-oxygenase and colon cancer: clues to the aspirin effect? Ann Med 1997;29:247-52. (Pubitemid 27292533)
7. Cascinu S, Ligi M, Del Ferro E, Foglietti G, Cioccolini P, Staccioli MP, et al. Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest 2000;18:411-6. (Pubitemid 30337521)
8. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9. (Pubitemid 46883748)
9. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-90. (Pubitemid 36297996)
10. Yamazaki R, Kusunoki N, Matsuzaki T, Hashimoto S, Kawai S. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Lett 2002;531:278-84. (Pubitemid 35341208)
11. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, et al. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterol 1997;113:1883-91. (Pubitemid 27512146)
12. Chan AT, Giovannucci EL, Schernhammer ES, Colditz GA, Hunter D J, Willett WC, et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med 2004;140:157-166.
13. Roderick PJ, Wilkes HC, Meade TW. The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol 1993;35:219-26. (Pubitemid 23074044)
14. Chan AT. Aspirin, non-steroidal anti-inflammatory drugs and colorectal neoplasia: future challenges in chemoprevention. Cancer Causes Contr 2003;14:413-8. (Pubitemid 36999975)
15. Pufulete M, Al-Ghnaniem R, Leather AJ, Appleby P, Gout S, Terry C, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterol 2003;124:1240-8. (Pubitemid 36531800)
16. Giovannucci E, StampferMJ, Colditz GA, Hunter DJ, Fuchs C, Rosner BA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998;129:517-24. (Pubitemid 28460290)
17. Baggott JE, Morgan SL, Ha T, Vaughn WH, Hine RJ. Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem J 1992;282:197-202.
18. Ma Q, Williamson KE, O'rourke D, Rowlands BJ. The effect of Larginine on crypt cell hyperproliferation in colorectal cancer. J Surg Res 1999;81:181-8. (Pubitemid 29397809)
19. Terry P, Baron JA, Bergkvist L, Holmberg L, Wolk A. Dietary calcium and vitamin D and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 2002;43:39-46. (Pubitemid 35387254)
20. Jacobs ET, Jurutka PW, Martinez ME, Alberts DS. Vitamin D, calcium and colorectal neoplasia: new insights on mechanisms of action. Cancer Prev Res 2009;2:197-9.
21. Chakrabarty S,Wang H, Canaff L, Hendy GN, Appelman H, Varani J. Calcium sensing receptor in human colon carcinoma: interaction with Ca(2+) and 1,25-dihydroxyvitamin D(3). Cancer Res 2005;65:493-8.
22. Kanthamneni N, Chaudhary A, Wang J, Prabhu S. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. Int J Oncol 2010;37:177-85.
23. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 2002;62:165-70. (Pubitemid 34074001)
24. Torrance CJ, Jackson PE, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, et al. Combinatorial chemoprevention of intestinal neoplasia. Nat Med 2000;6:1024-8.
25. Chaudhary A, Wang J, Prabhu S. Development and validation of a high-performance liquid chromatography method for the simultaneous determination of aspirin and folic acid from nano-particulate systems. Biomed Chromat 2010;24:919-25.
26. Li H, Schut HA, Conran P, Kramer PM, Lubet RA, Steele VE, et al. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis 1999;20:425-30. (Pubitemid 29112630)
27. Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999;340:101-7. (Pubitemid 29054844)
28. Bailey M, Williams NA, Wilson AD, Stokes CR. Probit: weighted probit regression analysis for estimation of biological activity. J Immunol Methods 1992;153:261-2.
29. Ross MH, Romrell LJ, Kaye GI. Histology. A text and atlas. 3rd ed. Baltimore, MD: Williams & Wilkins; 1995.
30. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 1997;57:1301-5. (Pubitemid 27152555)
31. Tozaki H, Komoike J, Tada C,Maruyama T, Terabe A, Suzuki T, et al. Chitosan capsules for colon specific drug delivery: Improvement of insulin absorption from the rat colon. J Pharm Sci 1997;86:1016-21. (Pubitemid 27382903)
32. Pretlow TP, Cheyer C, O'Riordan MA. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity. Int J Cancer 1994;56:599-602. (Pubitemid 24094414)
33. Takahasi S, Ogawa K, Ohshima H, Esumi H, Ito N, Sugimura T. Induction of aberrant crypt foci in the large intestine of F344 rats by oral administration of 2-amido-1-methyl-6-phenylimidazol[4,5-b]pyridine. Jpn J Cancer Res 1991;82:135-7.
34. Siddiqui IA, Adhami VM, Bharali DJ, Hafeez BB, Asim M, Khwaja SI, et al. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 2009;69:1712-6.
35. Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H. Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer 2010;62:883-90.
36. Siddiqui IA, Mukhtar H. Nanochemoprevention by bioactive food components: a perspective. Pharm Res 2010;27:1054-60.
37. Gupta V, Aseh A, Rios CN, Aggarwal BB, Mathur AB. Fabrication and characterization of silk fibroin derived curcumin nanoparticles for cancer therapy. Int J Nanomed 2009;4:115-22.
38. Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, et al. Polymeric nanoparticle encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy. J Nanobiotech 2007;5:1-18.
39. Chen T, Wong YS, Zheng W, Bai Y, Huang L. Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solution induce mitochondria mediated apoptosis in A375 human melanoma cells. Colloids Surf B Biointerfaces 2008;67:26-31.
40. Reddy BN. Studies with azoxymethane-rate preclinical model for assessing colon tumor development and chemoprevention. Environ Mol Mutagen 2004;44:26-35.
41. Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71. (Pubitemid 38008899)
42. Reddy BS, Wang CX, Kong AN, Khor TO, Zheng X, Steele VE, et al. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin and celecoxib in F344 rats. Cancer Res 2006;66:4542-6.
43. Reddy BS, Rao CV. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug, with D, L-alpha difluoromethylornithine, in diet. Cancer Res 1990;50:2562-8. (Pubitemid 20150183)
44. Lin J, Hsiao PW, Chiu TH, Chao TJ. Combination of Cox-2 and oxaliplatin increases growth inhibition and death in human colon cancer cells. Biochem Pharmacol 2005;70:658-67. (Pubitemid 41058700)
45. Steele VE, Rao CV, Zhang Y, Patlolla J, Boring D, Kopelovich L, et al. Chemopreventive efficacy of naproxen and no-naproxen in rodent models of colon, urinary bladder, and mammary cancers. Cancer Prev Res 2009;2:951-6.
46. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Ravi Kumar MN. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm Res 2006;23:184-95. (Pubitemid 43214675)
47. Sinha VR, Mittal BR, Bhutani KK, Kumria R. Colonic delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm 2004; 269:101-8. (Pubitemid 38032827)